InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (17 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
17
T+90 hit rate
0%
T+90 mean return
-24.3%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Mostafa Adam S., Chief Financial Officer. Insider active across 1 company, notably X4 Pharmaceuticals, Inc. Cumulatively, 26 filings have been recorded. Split: 0 buy · 17 sells. Total volume traded: €442k. History available since 15 June 2021. The latest transaction was filed on 12 February 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations26 total
850,000 shares0Common StockSEC:0001628280-25-005702:0
74,773 shares0Common StockSEC:0001628280-25-002708:0
230,645 shares0Common StockSEC:0001628280-24-042545:0
52,500 shares@ US$0.88289.6% of flowCommon StockSEC:0001628280-24-010279:0
27,721 shares@ US$1.00915.9% of flowCommon StockSEC:0001628280-24-004263:0
230,645 shares@ US$0.7336.0% of flowCommon StockSEC:0001628280-23-036758:0
230,645 shares0Common StockSEC:0001628280-23-036471:0
2,641 shares@ US$1.891.0% of flowCommon StockSEC:0001628280-23-024228:0
5,417 shares@ US$1.932.2% of flowCommon StockSEC:0001628280-23-023443:0
5,417 shares@ US$2.222.5% of flowCommon StockSEC:0001628280-23-022473:0
52,500 shares@ US$0.849.4% of flowCommon StockSEC:0001628280-23-007722:0
27,721 shares@ US$0.935.5% of flowCommon StockSEC:0001628280-23-003757:0
10,834 sharesCommon StockSEC:0001628280-22-023323:0
2,641 sharesCommon StockSEC:0001628280-22-018400:0
5,416 sharesCommon StockSEC:0001628280-22-018047:0
5,416 sharesCommon StockSEC:0001628280-22-017438:0
105,000 shares0Common StockSEC:0001628280-22-004497:0
27,721 sharesCommon StockSEC:0001628280-22-002511:0
10,832 shares@ US$5.1010.7% of flowCommon StockSEC:0001628280-21-017333
10,832 shares@ US$5.100.013% mcap38.1% of flowCommon StockSEC:0001628280-21-017333:0
2,641 shares@ US$6.643.3% of flowCommon StockSEC:0001628280-21-013299
2,641 shares@ US$6.640.0040% mcap11.9% of flowCommon StockSEC:0001628280-21-013299:0
16,250 shares0Common StockSEC:0001628280-21-012933
16,250 shares0Common StockSEC:0001628280-21-012933:0
16,250 shares0Common StockSEC:0001628280-21-012477
25 of 26 declarations
About Mostafa Adam S.
Adam S. Mostafa is the Chief Financial Officer at X4 Pharmaceuticals, Inc. He is responsible for the company's financial management, including budgeting and financial analysis. Mostafa plays a key role in strategic decision-making and managing financial resources.
